(Q30365791)

21 June 2017

title

Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process. (English)

1 reference

21 June 2017

1 reference

Barry Buckland

1

1 reference

21 June 2017

Robert Boulanger

2

1 reference

21 June 2017

Mireli Fino

3

1 reference

21 June 2017

Indresh Srivastava

4

1 reference

21 June 2017

Kathy Holtz

5

1 reference

21 June 2017

Nikolai Khramtsov

6

1 reference

21 June 2017

Clifton McPherson

7

1 reference

21 June 2017

Jamal Meghrous

8

1 reference

21 June 2017

Paul Kubera

9

1 reference

21 June 2017

Manon M J Cox

10

1 reference

21 June 2017

language of work or name

English

0 references

publication date

12 August 2014

1 reference

21 June 2017

1 reference

21 June 2017

volume

32

1 reference

21 June 2017

issue

42

1 reference

21 June 2017

page(s)

5496-5502

1 reference

Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

Vaccine process technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

Development of a simple and high-yielding fed-batch process for the production of influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

Immunochemical quantitation of antigens by single radial immunodiffusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

A fast track influenza virus vaccine produced in insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

A methodology for centrifuge selection for the separation of high solids density cell broths by visualisation of performance using windows of operation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

New approaches to confronting an imminent influenza pandemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

Insect cell technology is a versatile and robust vaccine manufacturing platform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.074

10.1016/J.VACCINE.2014.07.074

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference